ASIC3 | acid sensing (proton gated) ion channel 3 | 7q35
| 4.981 |
ABCB8 | ATP-binding cassette, sub-family B (MDR/TAP), member 8 | 7q36.1
| 4.828 |
SLC4A2 | solute carrier family 4 (anion exchanger), member 2 | 7q36.1
| 4.773 |
CDK5 | cyclin-dependent kinase 5 | 7q36
| 4.768 |
ATG9B | autophagy related 9B | 7q36
| 4.61 |
ICT1 | immature colon carcinoma transcript 1 | 17q25
| 4.118 |
GPER1 | G protein-coupled estrogen receptor 1 | 7p22
| 4.007 |
MIR152 | microRNA 152 | 17q21.32
| 3.956 |
LOC101928861 | NA | NA
| 3.937 |
COPZ2 | coatomer protein complex, subunit zeta 2 | 17q21.32
| 3.907 |
EFNA3 | ephrin-A3 | 1q21-q22
| 3.734 |
COL26A1 | collagen, type XXVI, alpha 1 | 7q22.1
| 3.552 |
PPP1R9B | protein phosphatase 1, regulatory subunit 9B | 17q21.33
| 3.506 |
FOSB | FBJ murine osteosarcoma viral oncogene homolog B | 19q13.3
| 3.416 |
GPATCH4 | G patch domain containing 4 | 1q22
| 3.404 |
APOA1BP | apolipoprotein A-I binding protein | 1q21
| 3.4 |
LOC100505666 | NA | NA
| 3.345 |
EFNA4 | ephrin-A4 | 1q21-q22
| 3.343 |
SPEG | SPEG complex locus | 2q35
| 3.336 |
PRRT4 | proline-rich transmembrane protein 4 | 7q32.1
| 3.329 |
HSPB1 | heat shock 27kDa protein 1 | 7q11.23
| 3.323 |
KCNH2 | potassium channel, voltage gated eag related subfamily H, member 2 | 7q36.1
| 3.293 |
NOS3 | nitric oxide synthase 3 (endothelial cell) | 7q36
| 3.263 |
LOC101929696 | NA | NA
| 3.207 |
LOC100130705 | NA | NA
| 3.193 |
PRKCA-AS1 | PRKCA antisense RNA 1 | 17q24.2
| 3.181 |
SGCA | sarcoglycan, alpha (50kDa dystrophin-associated glycoprotein) | 17q21
| 3.173 |
ATP6V1F | ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F | 7q32.1
| 3.137 |
MMD | monocyte to macrophage differentiation-associated | 17q
| 3.135 |
PRCC | papillary renal cell carcinoma (translocation-associated) | 1q21.1
| 3.102 |
PRCD | progressive rod-cone degeneration | 17q25.1
| 3.059 |
ADAM15 | ADAM metallopeptidase domain 15 | 1q21.3
| 3.024 |
URAHP | urate (hydroxyiso-) hydrolase, pseudogene | 16q24.3
| 2.999 |
SH2D3C | SH2 domain containing 3C | 9q33.1-q33.3
| 2.972 |
KCTD2 | potassium channel tetramerization domain containing 2 | 17q25.2
| 2.962 |
DNAJB2 | DnaJ (Hsp40) homolog, subfamily B, member 2 | 2q35
| 2.96 |
SEPT9 | septin 9 | 17q25.3
| 2.946 |
CDK5RAP3 | CDK5 regulatory subunit associated protein 3 | 17q21.2
| 2.943 |
HILS1 | histone linker H1 domain, spermatid-specific 1, pseudogene | 17q21.33
| 2.93 |
SLC35E4 | solute carrier family 35, member E4 | 22q12.2
| 2.927 |
SMARCD3 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3 | 7q35-q36
| 2.911 |
GPR146 | G protein-coupled receptor 146 | 7p22.3
| 2.882 |
PTK6 | protein tyrosine kinase 6 | 20q13.3
| 2.876 |
NBPF1 | neuroblastoma breakpoint family, member 1 | 1p36.13
| 2.864 |
C1QTNF6 | C1q and tumor necrosis factor related protein 6 | 22q13.1
| 2.846 |
LOC100506474 | NA | NA
| 2.833 |
C20orf195 | chromosome 20 open reading frame 195 | 20q13.33
| 2.833 |
TIMP2 | TIMP metallopeptidase inhibitor 2 | 17q25
| 2.821 |
FASTK | Fas-activated serine/threonine kinase | 7q35
| 2.816 |
FLJ45079 | NA | NA
| 2.812 |
LINC00189 | long intergenic non-protein coding RNA 189 | 21q22.11
| 2.811 |
LINC01354 | long intergenic non-protein coding RNA 1354 | 1q42.2
| 2.801 |
LTK | leukocyte receptor tyrosine kinase | 15q15.1-q21.1
| 2.8 |
SLC30A3 | solute carrier family 30 (zinc transporter), member 3 | 2p23.3
| 2.795 |
SRMS | src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites | 20q13.33
| 2.786 |
PBXIP1 | pre-B-cell leukemia homeobox interacting protein 1 | 1q22
| 2.78 |
ANP32E | acidic (leucine-rich) nuclear phosphoprotein 32 family, member E | 1q22
| 2.762 |
LOC730668 | NA | NA
| 2.748 |
RTN2 | reticulon 2 | 19q13.2-q13.3
| 2.74 |
PPDPF | pancreatic progenitor cell differentiation and proliferation factor | 20q13.33
| 2.735 |
TMUB1 | transmembrane and ubiquitin-like domain containing 1 | 7q36.1
| 2.735 |
JAKMIP1 | janus kinase and microtubule interacting protein 1 | 4p16.1
| 2.723 |
CYB561 | cytochrome b561 | 17q23.3
| 2.723 |
NFE2L1 | nuclear factor, erythroid 2-like 1 | 17q21.3
| 2.722 |
ARID3A | AT rich interactive domain 3A (BRIGHT-like) | 19p13.3
| 2.713 |
LOC285484 | NA | NA
| 2.711 |
CBX8 | chromobox homolog 8 | 17q25.3
| 2.696 |
LOC101928279 | NA | NA
| 2.68 |
AGAP3 | ArfGAP with GTPase domain, ankyrin repeat and PH domain 3 | 7q36.1
| 2.679 |
FAM163B | family with sequence similarity 163, member B | 9q34.2
| 2.673 |
GS1-259H13.2 | NA | NA
| 2.672 |
ENTPD2 | ectonucleoside triphosphate diphosphohydrolase 2 | 9q34
| 2.667 |
ARHGAP26 | Rho GTPase activating protein 26 | 5q31
| 2.666 |
PPM1N | protein phosphatase, Mg2+/Mn2+ dependent, 1N (putative) | 19q13.32
| 2.661 |
LGALS8 | lectin, galactoside-binding, soluble, 8 | 1q43
| 2.654 |
PTPRH | protein tyrosine phosphatase, receptor type, H | 19q13.4
| 2.647 |
RADIL | Ras association and DIL domains | 7p22.1
| 2.642 |
LGALS8-AS1 | LGALS8 antisense RNA 1 | 1q43
| 2.639 |
TP53I3 | tumor protein p53 inducible protein 3 | 2p23.3
| 2.635 |
CIZ1 | CDKN1A interacting zinc finger protein 1 | 9q34.1
| 2.634 |
DNM1 | dynamin 1 | 9q34
| 2.629 |
GAS8-AS1 | GAS8 antisense RNA 1 | 16q24.3
| 2.626 |
CDR2L | cerebellar degeneration-related protein 2-like | 17q25.1
| 2.62 |
SYT8 | synaptotagmin VIII | 11p15.5
| 2.619 |
PMVK | phosphomevalonate kinase | 1q21.3
| 2.618 |
HDGF | hepatoma-derived growth factor | 1q23.1
| 2.607 |
PAPOLB | poly(A) polymerase beta (testis specific) | 7p22.1
| 2.601 |
SNORD118 | small nucleolar RNA, C/D box 118 | 17p13.1
| 2.6 |
MIR3194 | microRNA 3194 | 20
| 2.599 |
PER1 | period circadian clock 1 | 17p13.1
| 2.597 |
CYGB | cytoglobin | 17q25.1
| 2.595 |
NPR1 | natriuretic peptide receptor 1 | 1q21-q22
| 2.59 |
WDR60 | WD repeat domain 60 | 7q36.3
| 2.588 |
ANKRD40 | ankyrin repeat domain 40 | 17q21.33
| 2.588 |
IL11 | interleukin 11 | 19q13.3-q13.4
| 2.577 |
HAPLN2 | hyaluronan and proteoglycan link protein 2 | 1q23.1
| 2.577 |
TMEM107 | transmembrane protein 107 | 17p13.1
| 2.563 |
SEMA4B | sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4B | 15q25
| 2.563 |
NPDC1 | neural proliferation, differentiation and control, 1 | 9q34.3
| 2.562 |
LFNG | LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase | 7p22.3
| 2.561 |
INSRR | insulin receptor-related receptor | 1q21-q23
| 2.561 |
ASB6 | ankyrin repeat and SOCS box containing 6 | 9q34.13
| 2.56 |
LRRC23 | leucine rich repeat containing 23 | 12p13
| 2.557 |
RAB3D | RAB3D, member RAS oncogene family | 19p13.2
| 2.556 |
VAMP2 | vesicle-associated membrane protein 2 (synaptobrevin 2) | 17p13.1
| 2.541 |
NACAD | NAC alpha domain containing | 7p13
| 2.541 |
AATK-AS1 | AATK antisense RNA 1 | 17q25.3
| 2.538 |
EXTL1 | exostosin-like glycosyltransferase 1 | 1p36.1
| 2.536 |
ZYX | zyxin | 7q32
| 2.532 |
C1QTNF1-AS1 | C1QTNF1 antisense RNA 1 | 17q25.3
| 2.528 |
AATK | apoptosis-associated tyrosine kinase | 17q25.3
| 2.523 |
B4GALNT4 | beta-1,4-N-acetyl-galactosaminyl transferase 4 | 11p15.5
| 2.523 |
ZNF282 | zinc finger protein 282 | 7q36.1
| 2.52 |
TSC22D4 | TSC22 domain family, member 4 | 7p21-p15
| 2.518 |
MIR6088 | microRNA 6088 | 19
| 2.513 |
SFXN3 | sideroflexin 3 | 10q24.32
| 2.513 |
DNM1P35 | dynamin 1 pseudogene 35 | 15q24.2
| 2.507 |
PDZD7 | PDZ domain containing 7 | 10q24.32
| 2.506 |
SLC29A2 | solute carrier family 29 (equilibrative nucleoside transporter), member 2 | 11q13
| 2.504 |
CA11 | carbonic anhydrase XI | 19q13.33
| 2.502 |
CBX2 | chromobox homolog 2 | 17q25.3
| 2.501 |
DLX6-AS1 | DLX6 antisense RNA 1 | 7q21.3
| 2.501 |
SAMD14 | sterile alpha motif domain containing 14 | 17q21.33
| 2.497 |
PYGO2 | pygopus family PHD finger 2 | 1q22
| 2.494 |
MIR593 | microRNA 593 | 7q32.1
| 2.475 |
DAND5 | DAN domain family member 5, BMP antagonist | 19p13
| 2.473 |
KIAA1522 | KIAA1522 | 1p35.1
| 2.462 |
IMP3 | IMP3, U3 small nucleolar ribonucleoprotein | 15q24
| 2.458 |
ACOT11 | acyl-CoA thioesterase 11 | 1p32.3
| 2.455 |
MIR642B | microRNA 642b | 19
| 2.455 |
MIR642A | microRNA 642a | 19q13.32
| 2.453 |
TFR2 | transferrin receptor 2 | 7q22
| 2.452 |
TNNI2 | troponin I type 2 (skeletal, fast) | 11p15.5
| 2.447 |
C9orf92 | chromosome 9 open reading frame 92 | 9p22.3
| 2.447 |
TLE6 | transducin-like enhancer of split 6 | 19p13.3
| 2.443 |
MIR6892 | microRNA 6892 | 7
| 2.442 |
GAL3ST4 | galactose-3-O-sulfotransferase 4 | 7q22.1
| 2.442 |
C1QTNF1 | C1q and tumor necrosis factor related protein 1 | 17q25
| 2.439 |
VASP | vasodilator-stimulated phosphoprotein | 19q13.32
| 2.438 |
LINC00673 | long intergenic non-protein coding RNA 673 | 17q24.3
| 2.437 |
NTRK1 | neurotrophic tyrosine kinase, receptor, type 1 | 1q21-q22
| 2.435 |
S100A6 | S100 calcium binding protein A6 | 1q21
| 2.434 |
TRIM54 | tripartite motif containing 54 | 2p23.3
| 2.432 |
ANKRD9 | ankyrin repeat domain 9 | 14q32.31
| 2.432 |
DLGAP1-AS1 | DLGAP1 antisense RNA 1 | 18p11.31
| 2.422 |
DNAJC5G | DnaJ (Hsp40) homolog, subfamily C, member 5 gamma | 2p23
| 2.42 |
LINC00486 | long intergenic non-protein coding RNA 486 | 2p22.3
| 2.418 |
LAMTOR4 | late endosomal/lysosomal adaptor, MAPK and MTOR activator 4 | 7q22
| 2.417 |
TTC24 | tetratricopeptide repeat domain 24 | 1q22
| 2.41 |
LOC100507351 | NA | NA
| 2.408 |
CA14 | carbonic anhydrase XIV | 1q21
| 2.407 |
LINC00582 | long intergenic non-protein coding RNA 582 | 1q42.2
| 2.405 |
MIR6883 | microRNA 6883 | 17
| 2.405 |
SSTR3 | somatostatin receptor 3 | 22q13.1
| 2.402 |
S100A2 | S100 calcium binding protein A2 | 1q21
| 2.4 |
SNX33 | sorting nexin 33 | 15q23
| 2.399 |
LOC101929698 | NA | NA
| 2.398 |
LOC100505920 | NA | NA
| 2.391 |
MMP15 | matrix metallopeptidase 15 (membrane-inserted) | 16q13
| 2.386 |
MIR3188 | microRNA 3188 | 19
| 2.384 |
MIR1207 | microRNA 1207 | 8
| 2.382 |
PLEKHO2 | pleckstrin homology domain containing, family O member 2 | 15q22.31
| 2.378 |
SRRM3 | serine/arginine repetitive matrix 3 | 7q11.23
| 2.376 |
PNPLA7 | patatin-like phospholipase domain containing 7 | 9q34.3
| 2.371 |
LOC101928034 | NA | NA
| 2.371 |
S100A4 | S100 calcium binding protein A4 | 1q12-q22
| 2.369 |
LOC101928509 | NA | NA
| 2.368 |
MYT1 | myelin transcription factor 1 | 20q13.33
| 2.368 |
S100A5 | S100 calcium binding protein A5 | 1q21
| 2.368 |
SEC1P | secretory blood group 1, pseudogene | 19q13.33
| 2.366 |
GPR68 | G protein-coupled receptor 68 | 14q31
| 2.366 |
DBP | D site of albumin promoter (albumin D-box) binding protein | 19q13.33
| 2.363 |
COLEC11 | collectin sub-family member 11 | 2p25.3
| 2.361 |
SYNJ2 | synaptojanin 2 | 6q25.3
| 2.36 |
COL9A3 | collagen, type IX, alpha 3 | 20q13.3
| 2.358 |
ZSCAN25 | zinc finger and SCAN domain containing 25 | 7q22.1
| 2.352 |
MIR4648 | microRNA 4648 | 7
| 2.352 |
JUND | jun D proto-oncogene | 19p13.2
| 2.352 |
KISS1R | KISS1 receptor | 19p13.3
| 2.347 |
FRA10AC1 | fragile site, folic acid type, rare, fra(10)(q23.3) or fra(10)(q24.2) candidate 1 | 10q23.33
| 2.346 |
C14orf2 | chromosome 14 open reading frame 2 | 14q32.33
| 2.346 |
RGS3 | regulator of G-protein signaling 3 | 9q32
| 2.345 |
DLX6 | distal-less homeobox 6 | 7q21.3
| 2.345 |
SPAST | spastin | 2p24-p21
| 2.342 |
LOC100996251 | NA | NA
| 2.34 |
DDIT4 | DNA-damage-inducible transcript 4 | 10q22.1
| 2.339 |
LRIG2 | leucine-rich repeats and immunoglobulin-like domains 2 | 1p13.1
| 2.338 |
LOC100289580 | NA | NA
| 2.337 |
TMEM190 | transmembrane protein 190 | 19q13.42
| 2.337 |
LOC101927539 | NA | NA
| 2.332 |
EPN3 | epsin 3 | 17q21.33
| 2.332 |
LOC100132174 | NA | NA
| 2.331 |
RBM28 | RNA binding motif protein 28 | 7q32.2
| 2.329 |
ZBTB7B | zinc finger and BTB domain containing 7B | 1q21.2
| 2.327 |
GIPR | gastric inhibitory polypeptide receptor | 19q13.2-q13.3
| 2.326 |
ILF2 | interleukin enhancer binding factor 2 | 1q21.3
| 2.326 |
TMEM242 | transmembrane protein 242 | 6q25.3
| 2.324 |
SH2D2A | SH2 domain containing 2A | 1q21
| 2.323 |
MIR8083 | microRNA 8083 | 1
| 2.321 |
SHC1 | SHC (Src homology 2 domain containing) transforming protein 1 | 1q21
| 2.32 |